Some people infected with HIV are teeming with virus, but don’t get sick. Their resistive powers probably come from a mix of ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Thanks to advancements in prevention and treatment, global HIV infection rates have dramatically declined in recent years. But HIV still affects over 38 million people around the world.

If there is an actual risk of transmission, the doctor may prescribe a 28-day course of HIV medications known as post-exposure prophylaxis (PEP). If started within 72 hours of a suspected exposure, ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The Centers for Disease Control and Prevention (CDC) issued a public health warning about prescription medications sold ...

Data suggest that the risk of a person living with HIV with an undetectable viral load transmitting the virus is essentially zero. The strategy called treatment as prevention (TasP) strongly supports ...

A preventative HIV medication, pre-exposure prophylaxis (PrEP), can also be prescribed to over-16s. It slashes the risk of contracting HIV, if it is taken correctly. Those who take post-exposure ...

Gilead says the deal, made just weeks after clinical trial results showed how well the drug works, will provide rapid and broad access to a medication that has the potential to end the decades ...